We report the clinical and morphological features of
an unusual hepatorenal disorder in 2 patients. The main clinical
features were early onset of cholestatic liver disease and progressive tubulointerstitial nephritis, leading to renal death in early childhood. Renal histology showed interstitial fibrosis, tubular atrophy and dilatation, glomerular cysts in the cortex and
periglomerular fibrosis; liver histology was characterized by portal
fibrosis and bile duct abnormalities. Evaluating the 12 patients
published in the literature, the long-term prognosis of the liver
function appears bad, suggesting the possibility of a combined liver
and kidney transplantation.
The association between congenital hepatic and renal
disease is intriguing and sometimes poses a difficult interpretation for the physician. Autosomal recessive polycystic kidney disease (AR-PKD) and nephronophthisis (NPH) are the renal problems known to be
associated with liver disease.1,2 There are instead situations in which the clinical picture poses numerous nosologic problems, and even the pathologic features are lacking the typical elements for a specific diagnosis. Furthermore, as kidney
transplantation is necessary for these patients, the physician also has
to face the long-term prognosis of the liver function, especially if a precise knowledge of the underlying disease is lacking.
We describe 2 children with an unusual hepatorenal disease and early
end-stage renal insufficiency. We also review the data of 12 children
from the literature3 with an associated early renal
death and cholestatic liver disease and discuss the role of a combined
liver and kidney transplant in these patients.
CASE REPORTS
Case 1
The patient is the product of a full-term, uncomplicated
pregnancy and delivery. He is the second child of unrelated, healthy parents; there is no family history of renal or liver disease. His
weight has always been below the third centile. At the age of 19 months, blood biochemistry was performed because of the mother's
positivity for hepatitis B surface antigen, and it showed a mild anemia
and increased values of aspartate aminotransferase (AST), alanine
aminotransferase (ALT), and gamma glutamyl transferase (GGT) (Table
1); plasma urea and creatinine
concentrations were 30 and 0.6 mg/dL (10.7 mmol/L and 53 µmol/L),
respectively. At the age of 2.5 years, he was referred to our hospital
because of the biochemical features of advanced renal failure, with
severe edema and circulatory overload, marked anemia, hypertension,
oligoanuria, and metabolic acidosis. The patient had been apparently
well and active until 2 weeks earlier, when he experienced a flu-like
symptomatology and a few days before admission his breathing became
labored. Laboratory studies, performed on the day of admission,
confirmed severe renal failure and showed moderate hepatocytolysis (AST and ALT were twice the normal values), and cholestasis (high plasma values of GGT and alkaline phosphatase (ALP), mild hypercholesterolemia without hyperbilirubinemia), [Table 1]. Coagulative tests have always
been normal. Serologic markers for hepatitis viruses (A, B, and C) were
negative. Normal values of
-1 antitrypsin, alphafetoprotein, cupremia, ceruloplasmin, and plasma ammonium, excluded the coexistence of the most common liver diseases. Ocular evaluation excluded retinal
involvement. Renal ultrasound showed small kidneys with homogeneous
echogenicity and loss of corticomedullary differentiation. Renal biopsy
(Fig 1), performed during initial admission,
showed interstitial fibrosis and diffuse inflammatory infiltrate,
tubular atrophy and dilatations, some glomeruli with cystic dilatation and others jalinized with periglomerular fibrosis. Immunofluorescence was negative. Chronic peritoneal dialysis was started on the day of
admission. On ultrasound, liver was increased in volume with regular
echostructure. Liver biopsy showed severe portal fibrosis with small
bile duct proliferation and without inflammatory cell infiltration (Fig
2). At the age of 3.5 years, severe itching developed and was associated with an increased concentration of serum
total bile acids. Cholestyramine treatment was not beneficial, whereas
ursodesossicholic acid markedly reduced the symptomatology. A
hepatobiliary scintigraphy (with TC 99M Disida) was
performed and confirmed mild intrahepatic cholestasis. This examination
showed a worsening of cholestasis 3 years later. The patient is now 6 years old and is maintained by chronic peritoneal dialysis. He has
hepatomegaly (5 cm below right costal margin) without clinical signs of
portal hypertension. Liver tests are reported in Table 1.
Fig. 1.
Renal biopsy of case 1. Mild diffuse inflammatory infiltrate;
cystically dilated proximal tubules, three glomerular cysts, some
glomeruli almost completely fibrotic, mild diffuse interstitial fibrosis. (Masson trichrome × 120.)
[View Larger Version of this Image (124K GIF file)]
Fig. 2.
Liver biopsy of case 1. Severe portal fibrosis without inflammatory
infiltration and mild proliferation of interlobular bile ducts. (Masson
trichromic × 120.)
[View Larger Version of this Image (149K GIF file)]
Case 2
The patient is the product of a full-term uncomplicated
pregnancy. He has no family history of renal or liver disease. The child had been apparently well until the age of 4.5 years, when polyuria, polydipsia, and ingravescent pallor developed. He was first
hospitalized in another hospital where laboratory data were consistent
with severe renal failure and cholestatic liver disease (high plasma
values of GGT and ALP and moderate increase of serum total bile acids
and cholesterol), with hepatocytolysis (Table 1). After 1 month of
conservative treatment, he was started on chronic peritoneal dialysis.
When he was referred to our hospital at the age of 5.5 years, he was in
poor general condition, had severe and diffuse itching, and
hypertension was not controlled by the usual treatment. Liver tests are
reported in Table 1. Blood tests of coagulation, ammoniemia,
ceruloplasmin, cupremia, and
-1 antitrypsin were within normal
ranges. Serologic markers for hepatitis viruses were negative.
Ultrasound images showed two kidneys at the inferior limit of normal
range, with loss of corticomedullary differentiation and diffuse
hyperechogenic structure; the liver had a normal size, morphology, and
echo structure.
Needle biopsy of kidney, represented only by cortical tissue, showed
tubular atrophy, severe interstitial fibrosis, mild inflammatory infiltrate, thrombosis of some arterioles, cystic aspect of some glomeruli, and sclerojalinization of others. Liver biopsy showed moderate portal fibrosis and paucity of interlobular bile ducts (ratio
of ducts to portal areas = 0.6).
At the age of 7 years he underwent renal transplantation, which failed
a few months later because of serious cyclosporine toxicity, probably
caused by the presence of cholestasis. Our patient showed cyclosporine
levels in the low range for the drug measured by a monoclonal
antibody-based radioimmunoassay (range 73 to 198 ng/mL) and very high
for the polyclonal antibody-based radioimmunoassay (range 901 to 2400 ng/mL), with a ratio of nonspecific-to-specific cyclosporine levels
ranging from 9 to more than 20 (normal value around 2.0). The dosage of
the drug was around 13 to 14 mg/kg/day. Furthermore, a fine needle
aspiration biopsy, performed 16 days after transplantation, showed
changes secondary to cyclosporine A toxicity together with rejection.
We have since lost the child to follow-up.
DISCUSSION
The 2 patients reported in this article have clinical and
pathologic features that do not conform to the childhood nephropathies known to be associated with hepatic involvement: AR-PKD and NPH with
congenital hepatic fibrosis. More recently a tubulointerstitial nephritis has been described associated with arteriohepatic dysplasia (Alagille syndrome).7 In fact our children showed: 1)
early onset of tubulointerstitial nephritis, leading to renal death within the first years of life; 2) renal histology characterized by
tubular atrophy and dilatation, interstitial and periglomerular fibrosis, and even by glomerular cysts in the cortex; 3) clinical and
laboratory signs of cholestasis; and 4) hepatic histology characterized
by portal fibrosis with bile duct proliferation in 1 patient and
paucity in the other.
We ruled out the diagnosis of AR-PKD and of NPH, because AR-PKD
manifests with renal enlargement,1,2 whereas our patients' kidneys were both small, without the typical collecting duct
ectasia,1,2 and because in the NPH complex the first
symptoms occur between 3 and 7 years of age and end-stage renal failure
(ESRF) is usually reached during the second decade of life. The hepatic
involvement of these nephropathies is typically represented by
congenital hepatic fibrosis, clinically characterized by minimal
disturbances of the liver function without
cholestasis.2,10,11
Alagille syndrome was excluded in the patient with bile duct paucity,
because of the absence of the typical clinical features.
We have reviewed 12 children (Table
2) from the literature,3
with a renal histologic pattern characterized by chronic tubulointerstitial lesions and cortical microcysts, with rapid progression to ESRF, and associated marked hepatic damage and cholestasis. Liver histology was represented by bile duct proliferation and portal fibrosis in all the cases, apart from the 2 patients described by Hyams7 and Tolia8 in which paucity
of bile ducts was present. For these 12 patients, especially for the
cases with onset in the first 2 years of life, it has been suggested that a NPH-like nephropathy associated with an unusual form of liver
disease could represent a new syndrome.4 Our 2 patients are
very similar, from the clinical and histologic point of view, to the 4 described by Popovic et al4, in whom the liver disease was
progressive.
|
Table 2.
Clinical and Laboratory Data on Patients From the Literature and on Our
Two Patients
[View Table]
|
In the other 9 patients described,3,5 the age of onset
of the disease and of ESRF is earlier (first year of life) than in our
patients but the overall prognosis was poor as for the 4 children
above.
It seems, therefore, that the 12 patients reported by the literature
have a poor overall prognosis and the liver function contributes to a
relevant part of it. It is tempting to speculate that, at some stage,
these patients with cholestasis and portal fibrosis will also need a
liver transplant.
Furthermore, 1 of our patients who underwent kidney
transplantation, lost his graft after 2 months and we believe that a
relevant part was played by cyclosporine toxicity. In fact, the liver
is the major site of the metabolism of this drug, through several cytochrome P450 isoenzymes, and also the primary excretion site via
biliary secretion and fecal elimination (more than 90% of the drug is
excreted in the bile, whereas less than 6% is excreted in the urine).
As cyclosporine A-associated nephrotoxicity has also been related to an
increase in circulating metabolites, resulting from severely disturbed
cyclosporine excretion, with parent drug level within the normal range,
this pattern has to be anticipated in those patients with severe liver
dysfunction12 (poor absorption and excretion of the drug
secondary to the cholestasis).
The clinical pattern of the liver disease in our patients and in
the ones described by Popovic4 could be similar to Byler disease. In effect, this disease comprises a heterogeneous group of
conditions, characterized by progressive intrahepatic cholestasis. Although serum GGT levels are usually normal in Byler disease, a
minority of older children demonstrate elevated levels.13 To date, liver transplantation is the only successful treatment for
this rare disease.14
Very recently17 mitochondrial respiratory enzyme
activity impairment has been shown to be responsible for a case of
tubulointerstitial nephritis associated with hepatic involvement
(hepatomegaly with cytolysis, anicteric cholestasis, and severe
pruritus; a liver biopsy revealed interportal fibrosis and
noninflammatory bile duct proliferation). The suspicion of
mitochondrial cytopathies was considered only in our first patient, but
the lactate/pyruvate ratio was normal, although the clinical picture is
very similar to the child described by Berard et al17. This
child had a combined liver and kidney transplantation and the renal and
hepatic functions tests are described as normal 20 months after
transplantation.
We conclude that the 2 patients described in this report have both
a tubulointerstitial nephropathy similar to NPH and a liver disease
with intrahepatic cholestasis. The clinical distinguishing features of
the 2 children reported in this study are: early onset of renal
impairment, particularly in the first case, with necessity of dialytic
treatment at the age of 2 years, and the presence of marked
cholestasis. The natural history of this pathologic entity in unknown.
After restoration of renal function with renal transplantation, the
long-term survival of these patients may depend on the progression of
the liver disease and, therefore, combined liver and kidney
transplantation could be considered for these children.
Received for publication Aug 20, 1996; accepted Mar 6, 1997.
Reprint requests to (G.M.) Dipartimento di Pediatria,
Università degli studi, Via Giustiniani 3, 35128 Padova, Italy.
AR-PKD, autosomal recessive polycystic kidney
disease.
NPH, nephronophthisis.
AST, aspartate aminotransferase.
ALT, alanine aminotransferase.
GGT, gamma glutamyl transferase.
ALP, alkaline phosphatase.
ESRF, end-stage renal failure.